Portola Data on Its Novel Syk Inhibitors and Novel Universal Factor Xa Inhibitor Antidote to be Presented at 2008 American Society of Hematology (ASH) Meeting
... (Syk) and its novel universal
Factor Xa inhibitor antidote
will be presented at the annual meeting of ... developing its universal Factor Xa inhibitor antidote
to neutralize the
effect of small molecule Factor ... Xa Inhibitor Antidote
for Reversal of Anticoagulation by Factor ...
Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis
... Phase 1c Study Demonstrates Dose-dependent Activity of antidote
DURHAM, N.C., May 14 /PRNewswire/ -- Regado Biosciences today ... inhibits Factor IXa, a protein that is critical to
blood coagulation. The antidote
component, RB007, is a complementary
nucleic acid that binds to and ...
MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler
... the development of an inhaled insulin product through MicroDose's QDose joint venture, and an inhaler for the systemic delivery of a nerve agent antidote
for the US Department of Defense, in collaboration with the University of Pittsburgh . MicroDose is also conducting internal development programs ...
HHS Secretary Leavitt Announces Members of the National Biodefense Science Board
... for possible association with
Gulf War syndrome and evaluated several antidotes to nerve agents. He was a
member of the team that developed the antidote
kit now carried by the
United States armed forces. His current research focuses on developing a
stand-alone detection system for airborne biological ...
Sarbanes-Oxley Act: The Next Y2K For IT Budgets?
... CHICAGO There are lots of concerns by companies today to start reviewing the Sarbanes-Oxley Act and its effects on the IT area. Is the act a healthy antidote
for devastated market faith? Adjunct Northwestern professor James Carlini explores in this week's edition of Carlinis Comments.
AIDS and tobacco are worldwide killers: Is bioscience doing enough to stop them?
... A Wisconsin-born leader in the World Health Organization has laid down an urgent challenge for bioscience researchers: Arrest AIDS and develop an antidote
to nicotine addiction, and the planet will be a safer and more productive place.
Tom Loftus, the former U.S. ambassador to Norway and the former ...
Whats in a name? Quite a bit, when youre competing in biotech
... researchers and just about anyone else in the crowd of nearly 20,000 attendees.
Room to Breathe also conveyed the sense that Wisconsin offers an antidote
to some of the congestive ills that stem from doing business where the traffic is far worse, the real-estate prices are far higher, and the quality ...
Human networks: an antidote to process ideology
... field of studying how humans behave in the corporate setting is also alive and well. The research on human workplace dynamics provides a refreshing antidote
to the process ber-orthodoxy that has become so prevalent. A particularly bright light in this field is Dr. Karen Stephenson, an anthropologist and ...
Madison-based Mithridion seeks to capitalize on Alzheimer's breakthrough
... itself on a three-year timeline to get to Phase I clinical trials.
Mithridion, which draws its name from the word mithridate, an antidote
for poison, has risen from combining the science of Johnson and Stein (soon to be Mithridion's chief scientific officer) with Twose's business ...
Dressing information technology in business clothes
... of XP, many organizations will remain on the sidelines.
That's too bad, because these narrative approaches or something like them are a good antidote
to the "solution-itis" that seems to be sweeping through IT these days. It's hard to jump into a pre-packaged "solution" once you've heard and ...
Midwest plays small role in VC investment, angel groups to the rescue
... watched as VC money gets harder and harder to access.
Angels are getting more and more sophisticated and forming small funds, and are a welcome antidote
to dwindling VC investment in start-up/seed ventures. Additionally if you add in key state-based incentives for angel investors, this group of ...